| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000030681 |
| Receipt No. | R000035031 |
| Official scientific title of the study | Sepsis-3 based evaluation of living donor liver transplantation: risk factor of sepsis onset and predictive factor of poor prognosis |
| Date of disclosure of the study information | 2018/01/05 |
| Last modified on | 2018/01/04 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Sepsis-3 based evaluation of living donor liver transplantation:
risk factor of sepsis onset and predictive factor of poor prognosis |
|
| Title of the study (Brief title) | Sepsis-3 based evaluation of living donor liver transplantation:
risk factor of sepsis onset and predictive factor of poor prognosis |
|
| Region |
|
|
| Condition | ||
| Condition | Patient at our hospital after living liver transplant surgery | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study was to clarify the risk factors of sepsis after LDLT on the basis of Sepsis-3 and the predictive factors of poor prognosis after the sepsis onset. |
| Basic objectives2 | Others |
| Basic objectives -Others | None |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the risk factors of sepsis after LDLT on the basis of Sepsis-3 and the predictive factors of poor prognosis after the sepsis onset. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent LDLT at our hospital between November 1997 and January 2017. | |||
| Key exclusion criteria | None | |||
| Target sample size | 64 | |||
| Research contact person | |
| Name of lead principal investigator | Sawada Yu |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Gastroenterological Surgery, |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan |
| TEL | 045-787-2800 |
| sawadadawasa2004@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Sawada Yu |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Gastroenterological Surgery, |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan |
| TEL | 045-787-2650 |
| Homepage URL | |
| sawadadawasa2004@yahoo.co.jp | |
| Sponsor | |
| Institute | Yokohama City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Preoperative factors, intraoperative factors and postoperative factors will be examined in the group with sepsis combined vs noncompliant group. We will also consider pathogenic bacteria and infected organs. We also compare the prognosis of nonseptic sepsis group and sepsis group. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035031 |